1. A. Spinks, The changing role of chemistry in product innovation, Chem. Ind. (London) 885 (1973).
2. P. Wardman, E. D. Clarke, I. R. Flockhart, and R. G. Wallace, The rationale for the development of improved hypoxic cell radiosensitizers, Br. J. Cancer 37:1 (1978).
3. P. Wardman, The chemical basis for the development of hypoxic cell radiosensitizers, in: “Radiosensitizers of Hypoxic Cells”, A. Breccia, C. Rimondi, and G. E. Adams, eds., Elsevier, Amsterdam (1979).
4. G. E. Adams, E. D. Clarke, I. R. Flockhart, R. S. Jacobs, D. S. Sehmi, I. J. Stratford, P. Wardman, M. E. Watts, J. Parrick, R. G. Wallace, and C. E. Smithen, Structure-activity relationships in the development of hypoxic cell radiosensitizers. I. Sensitization efficiency, Int. J. Radiat. Biol. 35:133 (1979).
5. G. E. Adams, E. D. Clarke, P. Gray, R. S. Jacobs, I. J. Stratford, P. Wardman, M. E. Watts, J. Parrick, R. G. Wallace, and C. E. Smithen, Structure-activity relationships in the development of hypoxic cell radiosensitizers. II. Cytotoxicity and therapeutic ratio, Int. J. Radiat. Biol., 35:151 (1979).